Software roared back last quarter. Cramer says these stocks can keep climbing

Software stocks rebounded strongly in Q3 as concerns that AI would disrupt established business models receded, with Salesforce, Microsoft, Workday and Veeva among the leading gainers. Jim Cramer expects further upside for major software leaders including Salesforce and Microsoft, but identifies higher interest rates as the principal risk entering the new quarter.

Analysis

The relevant differentiation is not broad “software” exposure but the ability to convert AI features into higher net retention, seat expansion, and pricing without materially raising inference costs. MSFT has the clearest distribution advantage through bundled enterprise workflows, but much of that monetization optionality is likely already embedded in its premium multiple. CRM and WDAY offer more asymmetric rerating potential if upcoming results show AI-driven pipeline conversion or stable gross margins while incorporating new functionality; VEEV remains more dependent on life-sciences IT budgets and customer migration execution than on a generalized AI narrative.

Over the next 1-3 months, the key catalyst is whether enterprise software guidance confirms that IT budgets are expanding rather than merely being reallocated toward hyperscalers and data infrastructure. A rate-driven selloff would likely hurt long-duration application software more than MSFT, creating a relative-value opportunity rather than invalidating the operating thesis. Over 6-18 months, the principal risk is that copilots become table-stakes features: vendors may incur higher cloud/inference expense while customers resist incremental price increases, compressing the rule-of-40 premium across SaaS. The thesis is falsified by declining net retention, a material increase in sales-and-marketing spend to sustain bookings, or AI-related gross-margin pressure in the next two reporting cycles.

Key Decisions for Investors

• Initiate a 3-6 month pair: long CRM / short IGV in equal beta-adjusted dollars. CRM has a clearer margin-expansion and capital-return pathway than the median SaaS constituent; target 10-15% relative outperformance, with a 7% relative stop if bookings growth decelerates or operating-margin guidance is cut.
• Maintain MSFT as the quality software overweight, but add only on a 5-8% rate-led pullback rather than chase strength. Use a 6-12 month horizon; risk/reward is approximately 2:1 if commercial-cloud growth and Copilot attach support estimates, but reduce if Azure growth misses consensus by more than 200bps.
• Treat WDAY as an earnings catalyst watch rather than a pre-emptive long. Buy only if next-quarter subscription backlog and large-enterprise pipeline accelerate while non-GAAP operating-margin guidance holds; this would support a 15-20% upside rerating over 6 months. A bookings miss or further federal/large-enterprise deal slippage invalidates the setup.
• Avoid broad long exposure to VEEV until migration progress and biopharma budget normalization are independently reflected in guidance. The better tactical expression is to own VEEV only against a short basket of lower-quality SaaS names if its retention and margin trajectory improves; otherwise its defensive growth premium remains vulnerable to real-yield upside.